AAAAAA

   
Results: 1-10 |
Results: 10
Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac
Authors: Giles, KM Ross, K Rossi, AG Hotchin, NA Haslett, C Dransfield, I
Citation: Km. Giles et al., Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac, J IMMUNOL, 167(2), 2001, pp. 976-986
Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway
Authors: Martin, MC Dransfield, I Haslett, C Rossi, AG
Citation: Mc. Martin et al., Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway, J BIOL CHEM, 276(48), 2001, pp. 45041-45050
Molecular characterization of the surface of apoptotic neutrophils: Implications for functional downregulation and recognition by phagocytes
Authors: Hart, SP Ross, JA Ross, K Haslett, C Dransfield, I
Citation: Sp. Hart et al., Molecular characterization of the surface of apoptotic neutrophils: Implications for functional downregulation and recognition by phagocytes, CELL DEAT D, 7(5), 2000, pp. 493-503
Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta(2)-integrins - Role of tyrosine kinases and Ca2+ mobilization
Authors: Ruchaud-Sparagano, MH Walker, TR Rossi, AG Haslett, C Dransfield, I
Citation: Mh. Ruchaud-sparagano et al., Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta(2)-integrins - Role of tyrosine kinases and Ca2+ mobilization, J BIOL CHEM, 275(21), 2000, pp. 15758-15764
Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro
Authors: Guckian, M Dransfield, I Hay, P Dalgleish, AG
Citation: M. Guckian et al., Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro, CLIN EXP IM, 121(3), 2000, pp. 472-479
An appetite for apoptotic cells? Controversies and challenges
Authors: Giles, KM Hart, SP Haslett, C Rossi, AG Dransfield, I
Citation: Km. Giles et al., An appetite for apoptotic cells? Controversies and challenges, BR J HAEM, 109(1), 2000, pp. 1-12
Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets
Authors: Ward, C Dransfield, I Chilvers, ER Haslett, C Rossi, AG
Citation: C. Ward et al., Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets, TRENDS PHAR, 20(12), 1999, pp. 503-509
Extracellular matrix proteins protect small cell lung cancer cells againstapoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
Authors: Sethi, T Rintoul, RC Moore, SM MacKinnon, AC Salter, D Choo, C Chilvers, ER Dransfield, I Donnelly, SC Strieter, R Haslett, C
Citation: T. Sethi et al., Extracellular matrix proteins protect small cell lung cancer cells againstapoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo, NAT MED, 5(6), 1999, pp. 662-668
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes
Authors: Liu, YQ Cousin, JM Hughes, J Van Damme, J Seckl, JR Haslett, C Dransfield, I Savill, J Rossi, AG
Citation: Yq. Liu et al., Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes, J IMMUNOL, 162(6), 1999, pp. 3639-3646
You can lead a macrophage to an inflammatory site but can you make it eat?
Authors: Hart, SP Rossi, AG Dransfield, I
Citation: Sp. Hart et al., You can lead a macrophage to an inflammatory site but can you make it eat?, BIOCH SOC T, 26(4), 1998, pp. 650-652
Risultati: 1-10 |